Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mark Sanz"'
Autor:
Krishnankutty Sudhir, Liming Hou, Mark Sanz, Hemal Gada, Donald E. Cutlip, William G. Newman, Kenneth W. Mahaffey, Gregg W. Stone, Kai Koo, Ajay J. Kirtane, James B. Hermiller
Publikováno v:
JACC: Cardiovascular Interventions. 6(12):1263-1266
Objectives This study sought to evaluate the long-term safety and efficacy of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES) in patients with obstructive coronary artery disease. Background The use of EES compared to PES has been
Autor:
Kai Koo, Krishnankutty Sudhir, Gregg W. Stone, Robert S. Smith, Mark Sanz, Naim Farhat, James B. Hermiller, Manejeh Yaqub, Poornima Sood, Ronald P. Caputo, Alexandra J. Lansky, Jerome Williams
Publikováno v:
EuroIntervention. 6:J44-J52
Aims and methods: T he rates of side branch occlusion and subsequent periprocedural MI during everolimuseluting stent (EES) and paclitaxel-eluting stent (PES) placement were examined in the randomised SPIRIT III trial. Periprocedural myocardial infar
Autor:
Julian Benetato Guiran, Gregg W. Stone, Mark Sanz, Ecaterina Cristea, Roseann White, William G. Newman, Halil Mutlu, Xiaolu Su, Poornima Sood, Alexandra J. Lansky, Vivian Ng, Julie Doostzadeh, Sherry Cao, Krishnankutty Sudhir, Mark Midei
Publikováno v:
Catheterization and Cardiovascular Interventions. 74:719-727
Objectives: We evaluated the role of gender on clinical and angiographic results of the everolimus-eluting stent in the SPIRIT III trial. Background: The SPIRIT III trial demonstrated superior efficacy of the XIENCE V everolimus-eluting stent compare
Autor:
Hemal, Gada, Ajay J, Kirtane, William, Newman, Mark, Sanz, James B, Hermiller, Kenneth W, Mahaffey, Donald E, Cutlip, Krishnankutty, Sudhir, Liming, Hou, Kai, Koo, Gregg W, Stone
Publikováno v:
JACC. Cardiovascular interventions. 6(12)
This study sought to evaluate the long-term safety and efficacy of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES) in patients with obstructive coronary artery disease.The use of EES compared to PES has been shown to result in imp
Autor:
Krishnankutty Sudhir, Poornima Sood, Eugenia Nikolsky, Alexandra J. Lansky, Robert J. Applegate, James B. Hermiller, Gregg W. Stone, Mark Sanz, Sherry Cao, Manejeh Yaqub
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 7(3)
Aims: Age is an important determinant of outcomes in patients treated with percutaneous coronary intervention (PCI). This report from the randomised multicentre SPIRIT III trial compares the outcomes in elderly and younger patients treated with evero
Autor:
Julie Doostzadeh, James B. Hermiller, Krishnankutty Sudhir, Mark Sanz, Gregg W. Stone, Wesley Pierson, Xiaolu Su, Robert J. Applegate, Alexandra J. Lansky
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 6(4)
AIMS To examine the two year clinical outcomes in dual-vessel disease from the SPIRIT III trial comparing the XIENCE V(r) everolimus-eluting stent (EES) to the TAXUS Express2(tm) paclitaxel-eluting stent (PES). METHODS AND RESULTS From a total of 1,0
Autor:
Ronald P. Caputo, William P. Newman, James B. Hermiller, Krishnankutty Sudhir, Robert J. Applegate, Jerome Williams, John L. Petersen, Mark Midei, Roseann White, Paul C. Gordon, Mark Sanz, Gregg W. Stone, Naim Farhat, Donald E. Cutlip, Nicholas P Xenopoulos
Publikováno v:
Circulation. 119(5)
Background— In the prospective randomized Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial, an everolimus-eluting stent (EES) co
Autor:
Gregg W, Stone, Mark, Midei, William, Newman, Mark, Sanz, James B, Hermiller, Jerome, Williams, Naim, Farhat, Kenneth W, Mahaffey, Donald E, Cutlip, Peter J, Fitzgerald, Poornima, Sood, Xiaolu, Su, Alexandra J, Lansky, S, Oxborough
Publikováno v:
JAMA. 299(16)
A thin, cobalt-chromium stent eluting the antiproliferative agent everolimus from a nonadhesive, durable fluoropolymer has shown promise in preliminary studies in improving clinical and angiographic outcomes in patients with coronary artery disease.T
Autor:
Lynn A. Smaha, David L. Brewer, Mark Sanz, Donald E. Casey, William J. French, Henry H. Ting, Richard W. Smalling
Publikováno v:
Circulation. 116(2)
The physician’s overarching role in the development of systems of care for ST-segment–elevation myocardial infarction (STEMI) is to advocate for achieving the goal of early infarct-artery patency for all patients with STEMI. An effective STEMI ca
Publikováno v:
Developments in Cardiovascular Medicine ISBN: 9789401070829
To increase the precision of the evaluation of coronary artery stenosis severity, we have implemented a digital radiographically based computer program which measures absolute and relative coronary artery dimensions using automated edge detection and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ef6de0a24f29633180efd7fdcc587c2
https://doi.org/10.1007/978-94-009-1309-7_9
https://doi.org/10.1007/978-94-009-1309-7_9